Advertisement
New Zealand markets closed
  • NZX 50

    11,931.32
    -2.99 (-0.03%)
     
  • NZD/USD

    0.5938
    -0.0061 (-1.02%)
     
  • NZD/EUR

    0.5573
    -0.0015 (-0.27%)
     
  • ALL ORDS

    8,050.20
    -23.90 (-0.30%)
     
  • ASX 200

    7,788.10
    -25.50 (-0.33%)
     
  • OIL

    85.45
    +0.43 (+0.51%)
     
  • GOLD

    2,360.20
    -12.50 (-0.53%)
     
  • NASDAQ

    18,003.49
    -304.50 (-1.66%)
     
  • FTSE

    7,995.58
    +71.78 (+0.91%)
     
  • Dow Jones

    37,983.24
    -475.84 (-1.24%)
     
  • DAX

    17,930.32
    -24.16 (-0.13%)
     
  • Hang Seng

    16,721.69
    -373.34 (-2.18%)
     
  • NIKKEI 225

    39,523.55
    +80.92 (+0.21%)
     
  • NZD/JPY

    90.9930
    -0.8880 (-0.97%)
     

Moderna’s Earnings Surprised the Street. Why One Analyst Says to Sell.

Moderna’s Earnings Surprised the Street. Why One Analyst Says to Sell.

Moderna shares were trading lower after a Wall Street firm turned bearish on the vaccine maker days after it issued strong quarterly results. HSBC Global Research analysts led by Yifeng Liu downgraded Moderna to Reduce from Hold but raised their price target to $86 from $75 in a Monday report. Moderna stock was down 3.8% to $92.78 in early afternoon trading, while Pfizer another maker of vaccines for Covid-19, was off 2%.